期刊文献+

老年COPD急性加重期血清IL-6、hs-CRP、α1-AG的检测及临床价值 被引量:4

Clinical value and detection of serum IL-6,hs-CRP,α1-AG in elderly patients with acute exacerbation chronic obstructive pulmonary disease
在线阅读 下载PDF
导出
摘要 目的探讨白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、α1酸性糖蛋白(α1-AG)在慢性阻塞性肺病急性加重期(AECOPD)老年患者血清中的表达变化和临床价值。方法运用ELISA法检测40例老年AECOPD患者治疗前后血清IL-6、hs-CRP、α1-AG含量,并与30例正常老年人比较,分析3个指标与AECOPD的关系。结果 COPD急性加重期IL-6、hs-CRP、α1-AG均高于缓解期,有显著性差异(P<0.01),实验组无论是加重期还是缓解期IL-6、hs-CRP、α1-AG均高于对照组,有显著性差异(P<0.01)。实验组加重期及缓解期3个指标两两比较均呈正相关性(P<0.05)。结论 IL-6、hs-CRP、α1-AG参与了老年COPD急性加重期的过程,3个指标对AECOPD早期诊断、治疗疗效评估有重要参考价值。 Objective To explore the expression and clinical value of serum interleukin -6 (IL-6) ,high sensitive C re- active protein (hs-CRP),alpha 1 acid glycoprotein (α1-AG) in elderly patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods Used ELISA to detect serum IL-6,hs-CRP,α1-AG in 40 elderly patients with a- cute exacerbation of COPD before and after treatment,compared with 30 healthy elderly patients, and analysed the relationship between the three indexes and AECOPD. Results The level of IL-6,hs-CRP,α1-AG in acute exacerbation of COPD were significantly higher than those in remission period. IL-6,hs-CRP,α1-AG levels of the experimental group were significantly higher than those in the control group in both exacerbation and remission. It was positive correlation between the three indexes in both the exacerbation of COPD and remission of COPD. Conclusion IL-6,hs-CRP and α1-AG participate the process of a- cute exacerbations of COPD, play an important role in diagnosing AECOPD in early stage and curative effect evaluation.
出处 《中国现代医药杂志》 2013年第11期17-19,共3页 Modern Medicine Journal of China
  • 相关文献

参考文献11

二级参考文献87

共引文献3953

同被引文献64

  • 1蒋芬,陈伟楚,潜丽俊,冯鑫,朱莲,茅海燕.磷酸奥司他韦对甲型流感病毒感染患儿淋巴细胞亚群及临床疗效影响[J].中国预防医学杂志,2020(9):974-978. 被引量:10
  • 2谢建霞.用糖皮质激素类药物治疗20例COPD急性加重期患者的效果观察[J].求医问药(下半月),2013(11):309-310. 被引量:1
  • 3Vestbo J,Hurd SS,Agust i AG,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2013,187(4):347-365.
  • 4Vestbo J,Hurd SS,Rodriguez-Roisin R.The 2011 revision of the global strategy for the diagnosis,management and prevention of COPD - why and what?[J].Clin Respir J,2012,6(4):208-214.
  • 5Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.(Updated.2014).Chap.2.[R].(2014-01- 18)[2014-01-18].http://www.goldcopd.org.
  • 6Global Initiative for Chronic Obstructive Lung Disease.Global Strategy for The Diagnosis,Management and Prevention of COFD.(Updated.2015).Chap.2.[R].(2015-01- 18)[2015-01-28].http://www.goldcopd.org.
  • 7Bafadhel M,Clark TW,Reid C,et al.Procalcitoniii and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD[J].Chest,2011,139(6):1410-1418.
  • 8Falsey AR,Becker KL,Swinburne AJ,et al.Utility of serum procalcitonin values in patients with acute exacerbations of chronicobstructive pulmonary disease:a cautionary note[J].Int J Chron Obstruct Pulmon Dis,2012(7):127-135.
  • 9张峰,王海明,叶甫澄.COPD急性加重期患者血气分析特点[J].现代中西医结合杂志,2012,21(10):1063-1065. 被引量:12
  • 10陈攀峰,蒋萍,吴永强.电子支气管镜检查在慢性阻塞性肺疾病急性加重期的应用[J].临床荟萃,2012,27(21):1878-1879. 被引量:2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部